AIM ImmunoTech (AIM) Stock: Buy, Sell, or Hold?
AIM - AIM ImmunoTech Inc.
$0.18
-0.01 (-4.10%)
▼
5d:
-5.31%
30d:
-23.27%
90d:
-39.39%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 16, 2026
Get Alerted When AIM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AIM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AIM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AIM is currently trading at $0.18, which is considered oversold relative to its 30-day fair value range of $0.19 to $0.24.
Technical Outlook: Technically, AIM is in a downtrend. Immediate support is located at $0.17, while resistance sits at $0.22. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: AIM scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AIM is in a downtrend. Immediate support is located at $0.17, while resistance sits at $0.22. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: AIM scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.19 -
$0.24
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
88.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.1%)
- CAUTION: Bottoming setup, but lagging the sector by 37% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-5.3%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.19 -
$0.24
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.17
Resistance Level
$0.22
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.49
Revenue Growth (YoY)
4.0%
Share & Embed Analysis
Last updated: October 03, 2026 5:27 PM ET
Data refreshes hourly during market hours. Next update: 6:27 PM
Data refreshes hourly during market hours. Next update: 6:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AIM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$570 | 55 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$199 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 63 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$63 | 60 BUY |
